Artis BioSolutions Announces Agreement to Acquire Syngoi Technologies to Deliver Next Generation Solutions for Synthetic DNA Technology
CMC in Advanced TherapiesFrom Risk to Readiness: How Smart CMC Strategy Defines Advanced Therapy Success